C-reactive protein and cancer risk: a pan-cancer study of prospective cohort and Mendelian randomization analysis (2022)
Attributed to:
UK Biobank (core renewal)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s12916-022-02506-x
PubMed Identifier: 36117174
Publication URI: http://europepmc.org/abstract/MED/36117174
Type: Journal Article/Review
Parent Publication: BMC Medicine
Issue: 1
ISSN: 1741-7015